Kevin Lobo bought $642K of GE HealthCare Technologies (GEHC)
Executed May 22, disclosed May 26, 4 days later.
Over the 21 trading sessions from the disclosed entry session (May 26), the stock returned +1.0% (delay-adjusted); from the execution session (May 22), -0.9%. Derived: entry at the session's open, exit at the close 20 sessions later.
Kevin Lobo (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in GE HealthCare Technologies Inc. (GEHC). Across 1 priced purchase filing, the average 21-session return was -0.9% from execution and +1.0% from disclosure (delay-adjusted; derived). The largest single filing was $642K of GEHC (10,000 sh × $64.18, as filed), executed May 22.
Healthcare · GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital sol…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→